Clinical and Biochemical Characterization of a Patient with Congenital Disorder of Glycosylation (CDG) IIx
Authors:
- Stacey K.H. TaySTStacey K.H. Tay
- Marion M. AwMAMarion M. Aw
- Erik A. EklundEEErik A. Eklund
- Hudson H. FreezeHFHudson H. Freeze
- 1 December 2005
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 147 (6) , 851-853
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporterBlood, 2005
- Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorderNature Medicine, 2004
- Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapiesEuropean Journal of Pediatrics, 2003
- Congenital disorders of glycosylation (CDG): It's all in it!Journal of Inherited Metabolic Disease, 2003
- Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie)Journal of Clinical Investigation, 2000
- A general approach to desalting oligosaccharides released from glycoproteinsGlycoconjugate Journal, 1998
- -N-Acetylgalactosamine-capping of chondroitin sulfate core region oligosaccharides primed on xylosidesGlycobiology, 1998
- A high-throughput microscale method to release N-linked oligosaccharides from glycoproteins for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysisGlycobiology, 1998
- Immune regulation by the ST6Gal sialyltransferaseProceedings of the National Academy of Sciences, 1998
- Carbohydrate‐deficient glycoprotein syndrome type IIJournal of Inherited Metabolic Disease, 1993